SNHG7: A Novel Vital Oncogenic Lncrna in Human Cancers.
Yong Zhou,Bo Tian,Jinming Tang,Jie Wu,Hui Wang,Zhining Wu,Xu Li,Desong Yang,Baihua Zhang,Yuhang Xiao,Ying Wang,Junliang Ma,Wenxiang Wang,Min Su
DOI: https://doi.org/10.1016/j.biopha.2020.109921
IF: 7.419
2020-01-01
Biomedicine & Pharmacotherapy
Abstract:Long noncoding RNAs (lncRNAs) are a group of RNAs that lack protein-coding ability, with lengths greater than 200 nucleotides. Increasing evidence has indicated that they mediate multiple physiological and pathological processes by regulating gene expression at the epigenetic, transcriptional, post-transcriptional, and translational levels. The deregulation of lncRNAs was demonstrated to have tumor suppressive or oncogenic effects, and thus, these molecules play vital regulatory roles in tumor initiation and progression. Small nucleolar RNA hostgene 7 (SNHG7) is a lncRNA located on chromosome 9q34.3. Different studies have explored the potential role of SNHG7 in the development and progression of multiple human malignancies such as bladder, breast, colorectal, esophageal, gastric, and prostate cancer, as well as osteosarcoma, among others, and high expression predicts poor prognosis and poor survival for such patients. Moreover, this molecule can promote proliferation and metastasis, while inhibiting apoptosis in cancer cells. The present review highlights the latest insights into the expression, functional roles, and molecular mechanisms of SNHG7 in different human malignancies.